The immune tolerance network: A new paradigm for developing tolerance-inducing therapies
- 1 July 2002
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (1) , 17-23
- https://doi.org/10.1067/mai.2002.124258
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- PHASE I TRIAL OF A HUMANIZED, Fc RECEPTOR NONBINDING OKT3 ANTIBODY, huOKT3??1 (Ala-Ala) IN THE TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1999
- Long-Term Clinical Efficacy of Grass-Pollen ImmunotherapyNew England Journal of Medicine, 1999
- COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISMTransplantation, 1999
- Defining the outcome of immunosuppression withdrawal after liver transplantationHepatology, 1998
- PRECLINICAL STUDIES OF ALLOGRAFT TOLERANCE IN RHESUS MONKEYSTransplantation, 1997
- Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: A review of efficacy and mechanismsAmerican Journal of Kidney Diseases, 1995
- Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptanceHepatology, 1993
- T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells.Proceedings of the National Academy of Sciences, 1988
- Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.The Journal of Experimental Medicine, 1987